Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 36.36
+2.48 (7.32%)
Sep 1, 2026, 4:08 PM HKT
Genscript Biotech Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 844.97 | 959.53 | 594.49 | 560.48 | 625.7 | 490.1 |
Revenue Growth | -11.94% | 61.40% | 6.07% | -10.42% | 27.67% | 25.39% |
Gross Profit Gross Profit Growth | 439.28 | 553.2 | 272.13 | 270.63 | 304.08 | 282.52 |
Operating Income Operating Income Growth | 125.7 | 255.25 | 9.28 | 26.19 | -437.98 | -379.29 |
Net Income Net Income Growth | -636.71 | -532.83 | 2,962 | -95.48 | -226.85 | -358.71 |
Earnings Per Share EPS Growth | -0.29 | -0.25 | 1.40 | -0.05 | -0.11 | -0.18 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Industrial Synthetic Biology Products Industrial Synthetic Biology Products Growth | 60.06 | 57.95 | 53.69 | 43.05 | 38.66 | 38.57 |
Operation Unit Operation Unit Growth | 68.13 | 66.07 | 56.89 | 53.15 | 56.12 | 9.59 |
Life-Science Services and Products Life-Science Services and Products Growth | 593.47 | 522.13 | 454.95 | 412.91 | 360.54 | 315.79 |
Eliminations Eliminations Growth | -79.6 | -75.31 | -66.05 | -58.13 | -71.64 | -24.03 |
Biologics Development Services Biologics Development Services Growth | 202.91 | 388.69 | 95.02 | 109.49 | 125.01 | 81.35 |
Total Total Growth | 844.97 | 959.53 | 594.49 | 560.48 | 625.7 | 490.1 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 810.27 | 812.22 | 621.24 | 1,928 | 1,464 | 1,406 |
Total Debt Total Debt Growth | 343.53 | 344.77 | 250 | 842.5 | 656.02 | 417.24 |
Net Cash (Debt) Net Cash Growth | 466.74 | 467.45 | 371.23 | 1,085 | 807.69 | 988.47 |
Net Cash Growth | -0.15% | 25.92% | -65.80% | 34.38% | -18.29% | 37.79% |
Net Cash Per Share Net Cash Per Share Growth | 0.21 | 0.21 | 0.17 | 0.51 | 0.39 | 0.49 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 139.57 | 325.52 | 75.65 | -286.91 | -120.29 | -136.79 |
Capital Expenditures CapEx Growth | -133.05 | -82.13 | -195.79 | -252.45 | -216.11 | -133.04 |
Free Cash Flow Free Cash Flow Growth | 6.52 | 243.39 | -120.14 | -539.36 | -336.41 | -269.83 |
Free Cash Flow Growth | -97.32% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.99% | 57.65% | 45.77% | 48.28% | 48.60% | 57.65% |
Operating Margin | 14.88% | 26.60% | 1.56% | 4.67% | -70.00% | -77.39% |
Pretax Margin | -69.81% | -49.04% | -28.73% | 30.13% | -68.99% | -105.56% |
Profit Margin | -75.35% | -55.53% | 498.22% | -17.04% | -36.26% | -73.19% |
FCF Margin | 0.77% | 25.36% | -20.21% | -96.23% | -53.76% | -55.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 0.92 | - | - | - |
Forward PE | 132.91 | 41.99 | 257.62 | 257.62 | 257.62 | 257.62 |
P/FCF Ratio | 1555.36 | 14.33 | - | - | - | - |
PS Ratio | 12.00 | 3.64 | 4.57 | 9.63 | 10.77 | 18.97 |